S. Sugai

发表

American College of Rheumatology classification criteria for Sjögren's syndrome: A data‐driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance Cohort

L. Criswell, C. Shiboski, S. Shiboski, 2012, Arthritis care & research.

A Comparative Study Between MR Sialography and Salivary Gland Scintigraphy in the Diagnosis of Sjögren Syndrome

M. Matoba, H. Tonami, I. Yamamoto, 2001, Journal of computer assisted tomography.

Revised Japanese criteria for Sjögren’s syndrome (1999): availability and validity

K. Tsubota, Y. Hayashi, N. Miyasaka, 2004, Modern rheumatology.

Clonality analysis of lymphoproliferative disorders in patients with Sjögren's syndrome

H. Umehara, K. Kitagawa, S. Sugai, 2007, Clinical and experimental immunology.

Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin’s Lymphomas: Results of a Japanese Phase II Study

Y. Ohashi, Y. Matsuno, M. Ogura, 2004, International journal of hematology.

A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease

T. Yoshino, R. Suzuki, M. Kojima, 2017, Modern rheumatology.

Clinical and Imaging Findings of Lymphoma in Patients with Sjögren Syndrome

M. Matoba, H. Tonami, I. Yamamoto, 2003, Journal of computer assisted tomography.

Malignant Lymphoma in Sjögren Syndrome

H. Tonami, I. Yamamoto, S. Sugai, 2004 .

Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: initial and follow-up imaging features.

M. Matoba, H. Tonami, I. Yamamoto, 2002, AJR. American journal of roentgenology.

Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines

S. Shimizu, S. Sugai, Y. Hirose, 1989, The Journal of experimental medicine.

A case of Sjögren's syndrome with insulin-dependent diabetes mellitus and autoimmune thyroid disease

S. Sugai, Y. Masaki, Masami Mouri, 1993 .

Clinical and pathological characteristics of Mikulicz's disease (IgG4-related plasmacytic exocrinopathy).

K. Imai, S. Sugai, Motohisa Yamamoto, 2005, Autoimmunity reviews.

Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders

K. Tsubota, K. Imai, Y. Shinomura, 2008, Annals of the rheumatic diseases.

Augmented expression of CD44 splice variants in lymphoproliferative disorder of the lacrimal gland in Sjögren's syndrome.

K. Tsubota, N. Miyasaka, I. Saito, 1997, Japanese journal of ophthalmology.

Augmented Expression of CD 44 Splice Variants in Lymphoproliferative Disorder of the Lacrimal Gland in Sjiigren ’ s Syndrome

K. Tsubota, N. Miyasaka, I. Saito, 2022 .

[Marginal zone lymphoma associated with Sjögren's syndrome and hepatitis C virus infection].

N. Ogawa, S. Sugai, H. Karasawa, 2001, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Lymphoproliferative disorders in Sjögren's syndrome.

S. Sugai, Y. Masaki, 2004, Autoimmunity reviews.

Monoclonal gammopathies in Japanese patients with Sjögren's syndrome

S. Shimizu, S. Sugai, Y. Hirose, 1985, Journal of Clinical Immunology.

[Rheumatoid factor idiotypes in patients with Sjögren's syndrome].

S. Sugai, Y. Ogawa, X. Chen, 1996, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Lymphoproliferative disorders in Japanese patients with Sjögren's syndrome.

S. Shimizu, S. Sugai, S. Konda, 1987 .

Non-IgM monoclonal gammopathy in patients with Sjögren's syndrome.

S. Sugai, S. Konda, T. Nishikawa, 1980, The American journal of medicine.

Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.

N. Ogawa, S. Sugai, L. Ping, 2002, Arthritis and rheumatism.

Epstein-Barr Virus-Associated B-Cell Type Non-Hodgkin’s Lymphoma with Concurrent p53 Protein Expression in a Rheumatoid Arthritis Patient Treated with Methotrexate

N. Ogawa, S. Sugai, Y. Masaki, 2002, International journal of hematology.

Malignant lymphomas in patients with autoimmune diseases: a report of 6 cases and a review of the Japanese literature.

S. Shimizu, S. Sugai, Y. Hirose, 1987, Japanese journal of medicine.

Leukemic transformation with trisomy 8 in essential thrombocythemia: a report of four cases

S. Sugai, Y. Masaki, Y. Hirose, 2002, European journal of haematology.

High prevalence of B-cell monoclonality in labial gland biopsies of Japanese Sjögren's syndrome patients.

P. Speight, S. Sugai, R. Jordan, 1996, International journal of hematology.

An early view of the international Sjögren's syndrome registry.

L. Criswell, C. Shiboski, S. Shiboski, 2009, Arthritis and rheumatism.

Expression of interferon-inducible T cell alpha chemoattractant (CXCL11) in the salivary glands of patients with Sjögren's syndrome.

K. Shimoyama, N. Ogawa, S. Sugai, 2004, Clinical immunology.

H. Umehara, S. Sugai, Y. Masaki, 2010, The Journal of Rheumatology.

Association of a new allele of the TAP2 gene, TAP2*Bky2 (Val577), with susceptibility to Sjögren's syndrome.

H. Saji, A. Morinobu, S. Sugai, 1997, Arthritis and rheumatism.

Thymus-antigen- and immunoglobulin- positive cells in lymph-nodes, thymus, and malignant lymphomas of NZB/NZW mice.

I. Weissman, G. Gutman, J. Greenspan, 1974, Clinical immunology and immunopathology.

Detection of apoptosis‐specific autoantibodies directed against granzyme B‐induced cleavage fragments of the SS‐B (La) autoantigen in sera from patients with primary Sjögren's syndrome

A. Hida, K. Eguchi, P. Utz, 2005, Clinical and experimental immunology.

A Case of Hypergammaglobulinemic Purpura Associated with Sjögren's Syndrome

S. Shimizu, S. Sugai, H. Ishizaki, 1993 .

Hypergammaglobulinemic purpura in patients with Sjögren's syndrome: a report of nine cases and a review of the Japanese literature.

S. Shimizu, S. Sugai, Y. Hirose, 1989, Japanese journal of medicine.

Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity

K. Tsubota, Y. Hayashi, N. Miyasaka, 2004 .

A monoclonal surface immunoglobulin (IgM/D-L) with specificity for surface antigen of ox red blood cells in a patient with leukemic lymphosarcoma

S. Shimizu, S. Sugai, S. Konda, 1986, Journal of Clinical Immunology.

Sjögren's syndrome associated with liver and neurological disorders, and malignant lymphoma.

S. Sugai, 2000, Internal medicine.

Mucosa-associated lympoid tissue (MALT) lymphoma and primary amyloidosis in the lung in Sjögren's syndrome.

S. Sugai, 2002, Internal medicine.

Interstitial cystitis and Sjögren's syndrome.

S. Sugai, 2004, Internal medicine.

Sweet's syndrome during therapy with granulocyte colony‐stimulating factor in a patient with aplastic anaemia

S. Shimizu, S. Sugai, Y. Ogawa, 1994, British journal of haematology.

Epstein-Barr Virus-Associated Anaplastic Large Cell Variant of Diffuse Large B-Cell-Type Non-Hodgkin’s Lymphoma with Concurrent P53 Protein Expression

K. Shimoyama, N. Ogawa, S. Sugai, 2003, International journal of hematology.

p38 Mitogen-activated Protein Kinase and Nuclear Factor-κB Facilitate CD40-mediated Salivary Epithelial Cell Death

N. Ogawa, S. Sugai, W. Xiao, 2012, The Journal of Rheumatology.

History: Lacrimal and Salivary Glands

S. Sugai, 2014 .

A high incidence of rheumatoid factor idiotypes in monoclonal proteins in the serum and in lymphoma cells in patients with Sjögren's syndrome.

S. Shimizu, S. Sugai, S. Imaoka, 1989, Journal of autoimmunity.

Sjögrens Syndrome, Glomerulonephritisand Malignant Lymphoma

S. Sugai, 2007 .

Sjögren's syndrome, glomerulonephritis and malignant lymphoma.

S. Sugai, 2007, Internal medicine.

[Sjögren's syndrome].

S. Sugai, 2005, Nihon rinsho. Japanese journal of clinical medicine.

CT and MR findings of bilateral lacrimal gland enlargement in Sjögren syndrome.

M. Matoba, H. Tonami, I. Yamamoto, 2002, Clinical imaging.

Monoclonal gammopathies in patients with Sjögren's syndrome.

S. Shimizu, S. Sugai, Y. Hirose, 1988, Japanese journal of medicine.

B cell malignant lymphoma in a patient with progressive systemic sclerosis and Sjögren's syndrome. Report of a case and review of the literature.

S. Shimizu, S. Sugai, F. Konishi, 1985, Japanese journal of medicine.

[Evaluation of the histologic criteria for the diagnosis of Sjögren's syndrome].

S. Sugai, Y. Ogawa, Y. Masaki, 1999, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Evaluation of the Raynaud's phenomenon by continuous monitoring of digital temperature prior to and following vasoconstrictory and vasodilatory treatment

S. Shimizu, S. Sugai, Y. Hirose, 1991 .

Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen.

Masao Tanaka, K. Itoh, T. Takegami, 2007, International immunology.

Syndrome: A Report of Nine Cases and a Review of the Japanese Literature

Yuko, Konda, S. Sugai, 2007 .

Thrombocytopenia in patients with Sjögren's syndrome.

S. Shimizu, S. Sugai, S. Konda, 1989, Arthritis and rheumatism.

Metastatic calcification in the stomach demonstrated by a bone scan in Bence Jones lambda myeloma.

S. Sugai, F. Konishi, Y. Hirose, 1987, Japanese journal of medicine.

Cutoff Values of Serum IgG4 and Histopathological IgG4+ Plasma Cells for Diagnosis of Patients with IgG4-Related Disease

Masao Tanaka, M. Kawano, S. Nishiyama, 2012, International journal of rheumatology.

CUTANEOUS LUPUS ERYTHEMATOSUS: DIRECT IMMUNOFLUORESCENCE AND EPIDERMAL BASAL MEMBRANE STUDY

S. Sugai, M. Sotto, M. N. Sotto, 1992, International journal of dermatology.

MR sialography in patients with Sjögren syndrome.

M. Matoba, H. Tonami, I. Yamamoto, 1998, AJNR. American journal of neuroradiology.

Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren’s syndrome: a double-blind placebo-controlled multicenter trial

M. Takei, S. Sawada, K. Yamaji, 2009, Modern rheumatology.

An established CD4+ T lymphoma cell line derived from a patient with so-called Lennert's lymphoma: possible roles of cytokines in histopathogenesis.

M. Matsuoka, S. Shimizu, S. Sugai, 1988, Blood.

Current and prospective treatment options for Sjögren’s syndrome

S. Sugai, Y. Masaki, 2008, Expert review of clinical immunology.

Efficacy and safety of mizoribine for the treatment of Sjögren's syndrome: a multicenter open-label clinical trial

T. Mimori, S. Ito, T. Sumida, 2007, Modern rheumatology.

[Long-term follow-up of 43 patients with Sjögren's syndrome].

S. Sugai, Y. Ogawa, Y. Masaki, 1997, Ryumachi. [Rheumatism].

Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.

H. Sakamoto, S. Sugai, A. Yachi, 1994, Hepato-gastroenterology.

Primary Sjögren's syndrome as a systemic disease: A study of participants enrolled in an International Sjögren's syndrome registry

L. Criswell, C. Shiboski, S. Shiboski, 2012, Arthritis care & research.

Interleukin-6 (B-cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3).

T. Hirano, S. Shimizu, T. Matsuda, 1988, Blood.

[Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].

K. Shimoyama, N. Ogawa, S. Sugai, 2003, Ryumachi. [Rheumatism].

Interleukin-7 (IL-7)-induced proliferation of CD8+ T-chronic lymphocytic leukemia cells

S. Shimizu, S. Sugai, Y. Hirose, 1992, Journal of Clinical Immunology.

Novel role of CD40 in Fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren's syndrome.

N. Ogawa, S. Sugai, L. Ping, 2005, Arthritis and rheumatism.

Analyses for binding of the transferrin family of proteins to the transferrin receptor 2

S. Sugai, H. Phillip Koeffler, X. Tong, 2004, British journal of haematology.

Gamma heavy chain disease and giant lymph node hyperplasia in a patient with impaired T cell function.

T. Toyama, S. Sugai, M. Kitagawa, 1982, Japanese journal of medicine.

PROTECTIVE AND CELLULAR IMMUNE RESPONSES TO IDIOTYPIC DETERMINANTS ON CELLS FROM A SPONTANEOUS LYMPHOMA OF NZB/NZW F1 MICE

I. Witz, N. Talal, S. Sugai, 1974, The Journal of experimental medicine.

Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis.

I. Narita, M. Kawano, H. Umehara, 2010, Kidney international.

Intravascular large B cell lymphoma: proposed of the strategy for early diagnosis and treatment of patients with rapid deteriorating condition

Masao Tanaka, K. Shimoyama, T. Nojima, 2009, International journal of hematology.

T-Cell Type Acute Lymphoblastic Leukemia Following Cyclosporin A Therapy for Aplastic Anemia

N. Ogawa, S. Sugai, Y. Masaki, 2001, International journal of hematology.

Sjögren's syndrome and sarcoidosis.

S. Sugai, 1998, Internal medicine.

Granulocytic sarcoma of megakaryoblastic differentiation in the lymph nodes terminating as acute megakaryoblastic leukemia in a case of chronic idiopathic myelofibrosis persisting for 16 years

K. Shimoyama, T. Nojima, S. Sugai, 2001, European journal of haematology.

Double Ph‐positive megakaryoblastic transformation of chronic myeloid leukemia

N. Ogawa, S. Sugai, Y. Masaki, 2002, European journal of haematology.

Diagnostic potential of tear proteomic patterns in Sjögren's syndrome.

Susumu Sugai, Nobuo Takahashi, S. Sugai, 2005, Journal of proteome research.

Urinary pseudouridine in patients with lymphoma: comparison with other clinical parameters.

K. Itoh, Toshio Suzuki, H. Umehara, 2006, Clinica chimica acta; international journal of clinical chemistry.

GammaHeavy Chain Disease and Giant Lymph Node Hyperplasia in a Patient with Impaired T cell Function

Yoichi, S. Sugai, Himeno, 2007 .

An unusual mouse myeloma protein binding native DNA.

N. Talal, S. Sugai, J. A. Dixon, 1975, Clinical and experimental immunology.

Systemic manifestations in Sjögren's syndrome.

S. Sugai, 2001, Internal medicine.

Rearrangement of the rheumatoid factor-related germline gene Vg and bcl-2 expression in lymphoproliferative disorders in patients with Sjögren's syndrome.

S. Shimizu, N. Miyasaka, I. Saito, 1994, Clinical immunology and immunopathology.

[Clinical significance of cevimeline hydrochloride in the treatment of dry mouth in patients with Sjögren's syndrome].

K. Shimoyama, N. Ogawa, S. Sugai, 2004, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

histopathogenesis called Lennert's lymphoma: possible roles of cytokines in An established CD4+ T lymphoma cell line derived from a patient with so-

M. Matsuoka, S. Shimizu, S. Sugai, 2011 .

lymphoma-derived T-cell line ( KT-3 ) Interleukin-6 ( B-cell stimulatory factor 2 )-dependent growth of a Lennert ' s

T. Hirano, S. Shimizu, T. Matsuda, 2005 .

H. Umehara, S. Sugai, Y. Masaki, 2011 .

Epstein-Barr virus study in malignant lymphoma in Sjögren's syndrome.

N. Ogawa, S. Sugai, Y. Ogawa, 1999, International journal of hematology.

Light and Electron Microscopic Study of Vacuolated Cells in Immunoblastic Lymphadenopathy‐like T‐Cell Lymphoma

S. Shimizu, S. Sugai, Y. Hirose, 1990, Japanese journal of cancer research : Gann.

Association of the glutathione S-transferase M1 homozygous null genotype with susceptibility to Sjögren's syndrome in Japanese individuals.

A. Morinobu, M. Koshiba, S. Sugai, 1999, Arthritis and rheumatism.

Primary Sjögren's syndrome as a systemic disease: A study of participants enrolled in an International Sjögren's syndrome registry

L. Criswell, C. Shiboski, S. Shiboski, 2012, Arthritis care & research.

An early view of the international Sjögren's syndrome registry.

L. Criswell, C. Shiboski, S. Shiboski, 2009, Arthritis and rheumatism.

Immunophenotypic Analysis of Various Blastic Crises in Chronic Myeloid Leukemia: Correlations between CD7 Expression and Response to Chemotherapy

N. Ogawa, S. Sugai, Y. Masaki, 2003, International journal of hematology.

DNA autosensitivity in two Japanese sisters.

S. Shimizu, S. Sugai, S. Konda, 1990, Arthritis and rheumatism.